November 9, 2020

10 Nov 20 | IL | Prestige BioPharma, Teva Israel | Prestige BioPharma and Teva Israel announce they have entered into an exclusive partnership and supply agreement for Prestige's Tuznue® (trastuzumab biosimilar) in Israel. Under the agreement, Prestige is responsi...

29 May 2020 | US | Alexion, Amgen | In a filing to the Securities and Exchange Commission, Alexion announces it has settled its eculizumab dispute with Amgen. Under the agreement, Amgen will receive a non-exclusive, royalty-free license to market its product from 01 Ma...

December 3, 2019

02 Dec 2019 | Alvotech, Kamada | Alvotech and Kamada announce agreement to commercialise six biosimilar products in Israel. The first product is expected to be launched in Israel in 2022.

06 Nov 2019 | All | Biogen, Samsung Bioepis | Biogen and Samsung Bioepis announce ...

Please reload

Biosimilars bulletin 

November 9, 2020

Please reload

Search by tags